SEC 13F Intelligence

Lynwood Capital Management Inc. / IMMX

Lynwood Capital Management Inc.’s Immix Biopharma Inc Position

Does Lynwood Capital Management Inc. own Immix Biopharma Inc (IMMX)? Yes — 405.0K shares worth $1M (+7.37% of its 13F portfolio) as of Q1 2024, up from 200.3K shares the prior filed quarter.

Position Value
$1M
Q1 2024
Shares
405.0K
% of Portfolio
+7.37%
Quarters Held
4
currently held

Position History IMMX

Reported value by quarter
Q4 ’21: $2MQ4 ’21Q4 ’22: $58,000Q4 ’22Q2 ’23: $538,673Q2 ’23Q1 ’24: $1MQ1 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2024405.0K$1M+7.37%
Q2 2023200.3K$538,673+0.68%
Q4 202225.0K$58,000+0.07%
Q4 2021565.3K$2M+1.93%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Lynwood Capital Management Inc.’s full portfolio or all institutional holders of IMMX.